Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1454 ARTÍCULOS , VIENDO DEL 136 AL 150
Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB; Alzheimer's Disease Neuroimaging Initiative.
Prog Neurobiol. 2014 Jun;117:20-40. doi: 10.1016/j.pneurobio.2014.02.004. Epub 2014 Feb 16.
Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M; ICTUS/DSA Group.
Phytomedicine. 2014 May 15;21(6):888-92. doi: 10.1016/j.phymed.2014.01.003. Epub 2014 Feb 16.
Wnt signaling in the nervous system and in Alzheimer's disease
Inestrosa NC, Varela-Nallar L.
J Mol Cell Biol. 2014 Feb;6(1):64-74. doi: 10.1093/jmcb/mjt051.
D-amino acid-based peptide inhibitors as early or preventative therapy in Alzheimer disease
Kumar J, Sim V.
Prion. 2014 Jan-Feb;8(1):119-24. doi: 10.4161/pri.28220.
Cellular membrane fluidity in amyloid precursor protein processing
Yang X, Sun GY, Eckert GP, Lee JC.
Mol Neurobiol. 2014 Aug;50(1):119-29. doi: 10.1007/s12035-014-8652-6. Epub 2014 Feb 20.
Network-wide dysregulation of calcium homeostasis in Alzheimer's disease
Brawek B, Garaschuk O.
Cell Tissue Res. 2014 Aug;357(2):427-38. doi: 10.1007/s00441-014-1798-8. Epub 2014 Feb 20.
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Yan R, Vassar R.
Lancet Neurol. 2014 Mar;13(3):319-29. doi: 10.1016/S1474-4422(13)70276-X. Epub 2014 Feb 17.
Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment
Serpente M, Bonsi R, Scarpini E, Galimberti D.
Neuroimmunomodulation. 2014;21(2-3):79-87. doi: 10.1159/000356529. Epub 2014 Feb 14.
The role of inflammasome in Alzheimer's disease
Liu L, Chan C.
Ageing Res Rev. 2014 May;15:6-15. doi: 10.1016/j.arr.2013.12.007. Epub 2014 Feb 19.
Metal protein attenuating compounds for the treatment of Alzheimer's dementia
Sampson EL, Jenagaratnam L, McShane R.
Cochrane Database Syst Rev. 2014 Feb 21;2014(2):CD005380. doi: 10.1002/14651858.CD005380.pub5.
Saravanaraman P, Chinnadurai RK, Boopathy R.
Rev Neurosci. 2014;25(2):231-46. doi: 10.1515/revneuro-2013-0056.
Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease
Jain P, Karthikeyan C, Moorthy NS, Waiker DK, Jain AK, Trivedi P.
Curr Drug Targets. 2014 May;15(5):539-50. doi: 10.2174/1389450115666140226112321.
Influence of anesthetics on Alzheimer's disease: biophysical, animal model, and clinical reports
Silverstein JH.
J Alzheimers Dis. 2014;40(4):839-48. doi: 10.3233/JAD-130815.
Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies
Brondino N, Re S, Boldrini A, Cuccomarino A, Lanati N, Barale F, Politi P.
ScientificWorldJournal. 2014 Jan 22;2014:174282. doi: 10.1155/2014/174282. eCollection 2014.
Retinoids as potential targets for Alzheimer's disease
Sodhi RK, Singh N.
Pharmacol Biochem Behav. 2014 May;120:117-23. doi: 10.1016/j.pbb.2014.02.016. Epub 2014 Feb 26.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.